Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$70.48 - $79.95 $525,710 - $596,347
-7,459 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$75.36 - $86.57 $377,252 - $433,369
-5,006 Reduced 40.16%
7,459 $567,000
Q2 2019

Aug 01, 2019

BUY
$83.92 - $108.88 $1.05 Million - $1.36 Million
12,465 New
12,465 $1.08 Million
Q1 2019

May 10, 2019

SELL
$85.97 - $108.09 $717,591 - $902,227
-8,347 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$78.25 - $107.92 $653,152 - $900,808
8,347 New
8,347 $725,000
Q1 2018

May 03, 2018

SELL
$95.91 - $107.26 $28,773 - $32,178
-300 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$97.26 - $116.2 $29,178 - $34,860
300
300 $31,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.